Healthcare provider profile · identity verified

Joyce M Dobbertin, M.D.,D.C.

Family Practice · LYNDON, VT · NPI 1649216292

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	429	111
Losartan Potassium	Losartan Potassium	400	102
Levothyroxine Sodium	Levothyroxine Sodium	320	78
Metoprolol Succinate	Metoprolol Succinate	268	75
Amlodipine Besylate	Amlodipine Besylate	256	72
Omeprazole	Omeprazole	204	61
Hydrochlorothiazide	Hydrochlorothiazide	175	53
Lisinopril	Lisinopril	153	42
Eliquis	Apixaban	143	38
Tramadol Hcl	Tramadol Hcl	125	23
Pantoprazole Sodium	Pantoprazole Sodium	124	30
Albuterol Sulfate Hfa	Albuterol Sulfate	123	41
Lorazepam	Lorazepam	123	44
Gabapentin	Gabapentin	119	41
Escitalopram Oxalate	Escitalopram Oxalate	114	33
Furosemide	Furosemide	108	34
Rosuvastatin Calcium	Rosuvastatin Calcium	98	25
Estradiol	Estradiol	97	35
Potassium Chloride	Potassium Chloride	95	32
Jardiance	Empagliflozin	93	20
Duloxetine Hcl	Duloxetine Hcl	91	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	86	25
Sertraline Hcl	Sertraline Hcl	83	24
Tamsulosin Hcl	Tamsulosin Hcl	83	22
Metformin Hcl	Metformin Hcl	82	23
Prednisone	Prednisone	76	47
Spironolactone	Spironolactone	75	22
Clonazepam	Clonazepam	72	19
Trazodone Hcl	Trazodone Hcl	67	20
Quetiapine Fumarate	Quetiapine Fumarate	64	13
Fluticasone Propionate	Fluticasone Propionate	63	26
Atenolol	Atenolol	54	15
Famotidine	Famotidine	54	18
Ropinirole Hcl	Ropinirole Hcl	54	suppressed
Xarelto	Rivaroxaban	51	12
Montelukast Sodium	Montelukast Sodium	50	13
Mirtazapine	Mirtazapine	48	19
Triamcinolone Acetonide	Triamcinolone Acetonide	45	27
Allopurinol	Allopurinol	44	12
Fentanyl	Fentanyl	44	suppressed
Glipizide Er	Glipizide	44	14
Memantine Hcl	Memantine Hcl	41	suppressed
Mounjaro	Tirzepatide	40	suppressed
Ibuprofen	Ibuprofen	39	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	38	suppressed
Pregabalin	Pregabalin	37	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	36	11
Torsemide	Torsemide	36	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	suppressed
Breo Ellipta	Fluticasone/Vilanterol	33	suppressed
Divalproex Sodium Er	Divalproex Sodium	33	suppressed
Fluconazole	Fluconazole	33	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	31	26
Ketoconazole	Ketoconazole	31	suppressed
Celecoxib	Celecoxib	30	14
Diazepam	Diazepam	30	suppressed
Bupropion Xl	Bupropion Hcl	29	12
Olanzapine	Olanzapine	29	suppressed
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Finasteride	Finasteride	28	suppressed
Ondansetron Odt	Ondansetron	28	13
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Nitroglycerin	Nitroglycerin	27	13
Symbicort	Budesonide/Formoterol Fumarate	27	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Creon	Lipase/Protease/Amylase	25	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	25	11
Cephalexin	Cephalexin	24	20
Meloxicam	Meloxicam	24	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Nystatin	Nystatin	22	13
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Morphine Sulfate	Morphine Sulfate	21	suppressed
Ozempic	Semaglutide	21	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Risperidone	Risperidone	20	suppressed
Carvedilol	Carvedilol	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	12
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Alendronate Sodium	Alendronate Sodium	18	suppressed
Amoxicillin	Amoxicillin	18	14
Metronidazole	Metronidazole	18	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	13
Warfarin Sodium	Warfarin Sodium	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	13
Baclofen	Baclofen	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Carbamazepine	Carbamazepine	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Loperamide	Loperamide Hcl	15	suppressed
Morphine Sulfate Er	Morphine Sulfate	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Azithromycin	Azithromycin	14	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	14	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	14	suppressed
Metformin Hcl Er	Metformin Hcl	14	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Enbrel Sureclick	Etanercept	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Isosorbide Mononitrate	Isosorbide Mononitrate	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Simvastatin	Simvastatin	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Methylphenidate Er	Methylphenidate Hcl	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Restasis	Cyclosporine	12	suppressed
Alprazolam	Alprazolam	11	suppressed
Epinephrine	Epinephrine	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error